{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:01:04Z","timestamp":1790179264660,"version":"4.1.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T00:00:00Z","timestamp":1628294400000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Federal Ministry for Education and Science (BMBF) within the programme InfectControl project FINAR2.0","award":["03ZZ0834A"],"award-info":[{"award-number":["03ZZ0834A"]}]},{"name":"German Ministry of Health","award":["1369-240"],"award-info":[{"award-number":["1369-240"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Candida glabrata is the second leading fungal pathogen causing candidaemia and invasive candidiasis in Europe. This yeast is recognized for its rapid ability to acquire antifungal drug resistance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>We systematically evaluated 176 C. glabrata isolates submitted to the German National Reference Center for Invasive Fungal Infections (NRZMyk) between 2015 and 2019 with regard to echinocandin and fluconazole susceptibility.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Susceptibility testing was performed using a reference protocol (EUCAST) and a range of commercial assays. Hot spot regions of the echinocandin target FKS genes were sequenced using Sanger sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 84 of 176 isolates were initially classified as anidulafungin-resistant based on EUCAST testing. Of those, 71 harboured mutations in the glucan synthase encoding FKS genes (13% in FKS1, 87% in FKS2). Significant differences in anidulafungin MICs were found between distinct mutation sites. 11 FKS wild-type (WT) isolates initially classified as resistant exhibited anidulafungin MICs fluctuating around the interpretation breakpoint upon re-testing with multiple assays. Two FKS WT isolates consistently showed high anidulafungin MICs and thus must be considered resistant despite the absence of target gene mutations. Over one-third of echinocandin-resistant strains displayed concomitant fluconazole resistance. Of those, isolates linked to bloodstream infection carrying a change at Ser-663 were associated with adverse clinical outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Resistant C. glabrata strains are emerging in Germany. Phenotypic echinocandin testing can result in misclassification of susceptible strains. FKS genotyping aids in detecting these strains, however, echinocandin resistance may occur despite a wild-type FKS genotype.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jacamr\/dlab122","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T19:10:19Z","timestamp":1626462619000},"source":"Crossref","is-referenced-by-count":42,"title":["Emergence of resistant<i>Candida glabrata<\/i>in Germany"],"prefix":"10.1093","volume":"3","author":[{"given":"Alexander Maximilian","family":"Aldejohann","sequence":"first","affiliation":[{"name":"Institute for Hygiene and Microbiology, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Herz","sequence":"additional","affiliation":[{"name":"Institute for Hygiene and Microbiology, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Martin","sequence":"additional","affiliation":[{"name":"Institute for Hygiene and Microbiology, University of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"Walther","sequence":"additional","affiliation":[{"name":"National Reference Center for Invasive Fungal Infections, Leibniz Institute for Natural Product Research and Infection Biology- Hans Knoell Institute, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kurzai","sequence":"additional","affiliation":[{"name":"Institute for Hygiene and Microbiology, University of W\u00fcrzburg, W\u00fcrzburg, Germany"},{"name":"National Reference Center for Invasive Fungal Infections, Leibniz Institute for Natural Product Research and Infection Biology- Hans Knoell Institute, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,7]]},"reference":[{"key":"2021080704571773800_dlab122-B1","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00134-012-2695-9","article-title":"Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study","volume":"38","author":"Tabah","year":"2012","journal-title":"Intensive Care Med"},{"key":"2021080704571773800_dlab122-B2","doi-asserted-by":"crossref","first-page":"e00111-18","DOI":"10.1128\/CMR.00111-18","article-title":"Candida parapsilosis: from Genes to the Bedside","volume":"32","author":"Toth","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"2021080704571773800_dlab122-B3","doi-asserted-by":"crossref","first-page":"e1006290","DOI":"10.1371\/journal.ppat.1006290","article-title":"Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally","volume":"13","author":"Chowdhary","year":"2017","journal-title":"PLoS Pathog"},{"key":"2021080704571773800_dlab122-B4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/jof4030105","article-title":"Fungal resistance to echinocandins and the MDR phenomenon in Candida glabrata","volume":"4","author":"Healey","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"2021080704571773800_dlab122-B5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2021080704571773800_dlab122-B6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp","volume":"18","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2021080704571773800_dlab122-B7","first-page":"271","article-title":"Invasive fungal infection","volume":"116","author":"von Lilienfeld-Toal","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"2021080704571773800_dlab122-B8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/myc.12816","article-title":"Epidemiology of fungaemia in Sweden: a nationwide retrospective observational survey","volume":"61","author":"Klingspor","year":"2018","journal-title":"Mycoses"},{"key":"2021080704571773800_dlab122-B9","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1016\/S1473-3099(17)30304-3","article-title":"Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer","volume":"17","author":"Colombo","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2021080704571773800_dlab122-B10","first-page":"219","article-title":"Resistance to echinocandin antifungal agents in the United Kingdom in clinical isolates of Candida glabrata: Fifteen years of interpretation and assessment","volume":"58","author":"Fraser","year":"2019","journal-title":"Med Mycol"},{"key":"2021080704571773800_dlab122-B11","first-page":"316","article-title":"Host response to Candida albicans bloodstream infection and sepsis","volume":"6","author":"Duggan","year":"2015","journal-title":"Virulence"},{"key":"2021080704571773800_dlab122-B12","doi-asserted-by":"crossref","first-page":"e0194210","DOI":"10.1371\/journal.pone.0194210","article-title":"ICU mortality following ICU-acquired primary bloodstream infections according to the type of pathogen: a prospective cohort study in 937 Germany ICUs (2006-2015)","volume":"13","author":"Schwab","year":"2018","journal-title":"PLoS One"},{"key":"2021080704571773800_dlab122-B13","doi-asserted-by":"crossref","first-page":"e00591","DOI":"10.1128\/AAC.00591-18","article-title":"Clonal spread of Candida glabrata bloodstream isolates and fluconazole resistance affected by prolonged exposure: a 12-year single-center study in Belgium","volume":"62","author":"Goemaere","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijantimicag.2017.05.019","article-title":"Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management","volume":"50","author":"Farmakiotis","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"2021080704571773800_dlab122-B15","doi-asserted-by":"crossref","first-page":"e00906-17","DOI":"10.1128\/AAC.00906-17","article-title":"Monitoring antifungal resistance in a global collection of invasive yeasts and molds: application of CLSI epidemiological cutoff values and whole-genome sequencing analysis for detection of azole resistance in Candida albicans","volume":"61","author":"Castanheira","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fmb.11.19","article-title":"Current perspectives on echinocandin class drugs","volume":"6","author":"Perlin","year":"2011","journal-title":"Future Microbiol"},{"key":"2021080704571773800_dlab122-B17","first-page":"53","article-title":"Alpha- and \u03b2-1,3-glucan synthesis and remodeling","volume":"425","author":"Wagener","year":"2020","journal-title":"Curr Top Microbiol Immunol"},{"key":"2021080704571773800_dlab122-B18","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1128\/AAC.00813-12","article-title":"Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance","volume":"56","author":"Katiyar","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/jof6030143","article-title":"Differential regulation of echinocandin targets Fks1 and Fks2 in Candida glabrata by the post-transcriptional regulator Ssd1","volume":"6","author":"Healey","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2021080704571773800_dlab122-B20","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/AAC.00443-09","article-title":"Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-\u03b2-D-glucan synthase: implication for the existing susceptibility breakpoint","volume":"53","author":"Garcia-Effron","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B21","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1128\/AAC.00349-06","article-title":"Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility","volume":"50","author":"Katiyar","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B22","doi-asserted-by":"crossref","first-page":"e00195-18","DOI":"10.1128\/AAC.00195-18","article-title":"Absence of Azole or echinocandin resistance in Candida glabrata isolates in India despite background prevalence of strains with defects in the DNA mismatch repair pathway","volume":"62","author":"Singh","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B23","doi-asserted-by":"crossref","first-page":"S445","DOI":"10.1093\/infdis\/jix131","article-title":"Multidrug-resistant candida: epidemiology, molecular mechanisms, and treatment","volume":"216","author":"Arendrup","year":"2017","journal-title":"J Infect Dis"},{"key":"2021080704571773800_dlab122-B24","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2021080704571773800_dlab122-B25","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008\u20132011","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021080704571773800_dlab122-B26","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/AAC.00027-12","article-title":"The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata","volume":"56","author":"Shields","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/myc.12472","article-title":"Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria","volume":"59","author":"Klotz","year":"2016","journal-title":"Mycoses"},{"key":"2021080704571773800_dlab122-B28","author":"Arendrup","year":"2020"},{"key":"2021080704571773800_dlab122-B29","author":"CLSI","year":"2017"},{"key":"2021080704571773800_dlab122-B30","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1128\/JCM.02316-09","article-title":"Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates","volume":"48","author":"Cuenca-Estrella","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2021080704571773800_dlab122-B31","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1128\/JCM.02445-09","article-title":"Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2021080704571773800_dlab122-B32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.diagmicrobio.2012.05.008","article-title":"Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values","volume":"73","author":"Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021080704571773800_dlab122-B33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/myc.12929","article-title":"Comparison of fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata resistance to micafungin: a systematic review and meta-analysis","volume":"62","author":"Bienvenu","year":"2019","journal-title":"Mycoses"},{"key":"2021080704571773800_dlab122-B34","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1128\/AAC.01574-16","article-title":"Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata","volume":"60","author":"Zhao","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/AAC.01256-09","article-title":"Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media","volume":"54","author":"Arendrup","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B36","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am J Med"},{"key":"2021080704571773800_dlab122-B37","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s40265-014-0286-5","article-title":"Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management","volume":"74","author":"Perlin","year":"2014","journal-title":"Drugs"},{"key":"2021080704571773800_dlab122-B38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3767\/003158513X665070","article-title":"DNA barcoding in Mucorales: an inventory of biodiversity","volume":"30","author":"Walther","year":"2013","journal-title":"Persoonia"},{"key":"2021080704571773800_dlab122-B39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1439-0507.1998.tb00321.x","article-title":"Gerrits van den Ende AH. Molecular diagnostics of clinical strains of filamentous Basidiomycetes","volume":"41","author":"de Hoog","year":"1998","journal-title":"Mycoses"},{"key":"2021080704571773800_dlab122-B40","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1128\/jb.172.8.4238-4246.1990","article-title":"Rapid genetic identification and mapping of enzymatically amplified ribosomal DNA from several Cryptococcus species","volume":"172","author":"Vilgalys","year":"1990","journal-title":"J Bacteriol"},{"key":"2021080704571773800_dlab122-B41","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-372180-8.50042-1","volume-title":"Amplification and Direct Sequencing of Fungal Ribosomal RNA Genes for Phylogenetics","author":"White","year":"1990"},{"key":"2021080704571773800_dlab122-B42","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1128\/AAC.00836-10","article-title":"FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance","volume":"54","author":"Zimbeck","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B43","author":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs for antifungal agents v","year":"2020"},{"key":"2021080704571773800_dlab122-B44","author":"CLSI","year":"2017"},{"key":"2021080704571773800_dlab122-B45","doi-asserted-by":"crossref","first-page":"20150460","DOI":"10.1098\/rstb.2015.0460","article-title":"Clinical implications of globally emerging azole resistance in Aspergillus fumigatus","volume":"371","author":"Meis","year":"2016","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2021080704571773800_dlab122-B46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","article-title":"Treatment strategies for cryptococcal infection: challenges, advances and future outlook","volume":"19","author":"Iyer","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"2021080704571773800_dlab122-B47","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2217\/fmb-2018-0059","article-title":"Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside","volume":"13","author":"Beardsley","year":"2018","journal-title":"Future Microbiol"},{"key":"2021080704571773800_dlab122-B48","doi-asserted-by":"crossref","first-page":"e01628-18","DOI":"10.1128\/AAC.01628-18","article-title":"Comparative genomics of serial Candida glabrata isolates and the rapid acquisition of echinocandin resistance during therapy","volume":"63","author":"Barber","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B49","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1128\/AAC.03255-14","article-title":"Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance","volume":"58","author":"Pham","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B50","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/JCM.03378-13","article-title":"Development of a Luminex-based multiplex assay for detection of mutations conferring resistance to Echinocandins in Candida glabrata","volume":"52","author":"Pham","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2021080704571773800_dlab122-B51","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3389\/fmicb.2019.01585","article-title":"Clinical and Laboratory Development of Echinocandin Resistance in Candida glabrata: molecular Characterization","volume":"10","author":"Rivero-Menendez","year":"2019","journal-title":"Front Microbiol"},{"key":"2021080704571773800_dlab122-B52","doi-asserted-by":"crossref","first-page":"e01692-18","DOI":"10.1128\/AAC.01692-18","article-title":"Spontaneous mutational frequency and FKS mutation rates vary by echinocandin agent against Candida glabrata","volume":"63","author":"Shields","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B53","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.01674-13","article-title":"Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B54","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/cid\/civ791","article-title":"Echinocandin resistance in candida","volume":"61","author":"Perlin","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021080704571773800_dlab122-B55","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1128\/AAC.06369-11","article-title":"Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations","volume":"56","author":"Arendrup","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B56","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1128\/AAC.00044-11","article-title":"Candida glabrata mutants demonstrating paradoxical reduced caspofungin susceptibility but increased micafungin susceptibility","volume":"55","author":"Healey","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B57","doi-asserted-by":"crossref","first-page":"e02503-18","DOI":"10.1128\/AAC.02503-18","article-title":"Low level of antifungal resistance in iranian isolates of Candida glabrata recovered from blood samples in a multicenter study from 2015 to 2018 and potential prognostic values of genotyping and sequencing of PDR1","volume":"63","author":"Arastehfar","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2021080704571773800_dlab122-B58","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3389\/fmicb.2018.01523","article-title":"Multilocus Sequence Typing (MLST) genotypes of Candida glabrata bloodstream isolates in Korea: association with antifungal resistance, mutations in mismatch repair gene (Msh2), and clinical outcomes","volume":"9","author":"Byun","year":"2018","journal-title":"Front Microbiol"},{"key":"2021080704571773800_dlab122-B59","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/cid\/ciu407","article-title":"FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia","volume":"59","author":"Beyda","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021080704571773800_dlab122-B60","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/myc.13104","article-title":"Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure","volume":"63","author":"Arastehfar","year":"2020","journal-title":"Mycoses"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jacamr\/article-pdf\/3\/3\/dlab122\/39604729\/dlab122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jacamr\/article-pdf\/3\/3\/dlab122\/39604729\/dlab122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T04:50:38Z","timestamp":1699246238000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlab122\/6344817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,12]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7,12]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlab122","relation":{},"ISSN":["2632-1823"],"issn-type":[{"value":"2632-1823","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,1]]},"published":{"date-parts":[[2021,7,12]]},"article-number":"dlab122"}}